STOCK TITAN

Akoustis Announces Proposed Public Offering of Common Stock

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Akoustis Technologies, Inc. (AKTS) plans to offer and sell shares of its common stock in an underwritten public offering. The company expects to grant the underwriters a 30-day option to purchase additional shares. The offering is subject to market conditions, and the net proceeds will be used for operations, capital expenditures, research and development, commercialization of its technology, potential strategic transactions, and general corporate purposes.
Positive
  • None.
Negative
  • None.

Insights

The announcement by Akoustis Technologies, Inc. of its intention to conduct an underwritten public offering represents a pivotal financial event that could significantly affect the company's capital structure and liquidity. The decision to potentially offer additional shares to cover over-allotments, commonly known as a 'greenshoe option', is a standard practice that provides stability to a stock's price post-offering. This move indicates the company's proactive approach to secure additional funding, which could be seen as a positive signal to investors about management's confidence in the company's growth prospects.

However, the dilutive effect of issuing new shares could potentially weigh on the current stock price, as it may reduce earnings per share for existing stockholders. The market's reception of this offering will largely depend on the perceived use of proceeds. In Akoustis' case, the stated use for funding operations, capital expenditures and R&D could foster investor optimism if these areas are believed to drive future revenue growth and market expansion. Nevertheless, investors should closely monitor the final terms of the offering, including pricing and the total number of shares to be sold, as these will directly impact the company's valuation and the stock's performance.

From a market perspective, Akoustis Technologies operates within the high-band RF filter market, which is critical for mobile and wireless communication devices. The demand for these components is generally robust, driven by the continuous evolution of wireless standards and the proliferation of connected devices. The company's intention to use the proceeds for the commercialization of its technology suggests a strategic move to capitalize on this growing market.

Investors should consider the competitive landscape and the company's position within it. If Akoustis can successfully leverage the raised capital to enhance its product offerings and gain market share, it could emerge as a stronger player in the RF filter space. However, the effectiveness of these strategies in translating into financial performance is a key factor that will determine the long-term impact of this capital raise on the company's stock.

The offering's compliance with SEC regulations, as indicated by the effective shelf registration statement and the forthcoming filing of a preliminary prospectus supplement, is a crucial legal aspect of this transaction. It underscores the company's adherence to disclosure and regulatory requirements, which is essential for maintaining investor trust. Potential investors should review these documents thoroughly to understand the risks and specifics of the offering.

Moreover, the participation of the company's directors, officers and other employees in the offering could be perceived as an endorsement of the company's future, although it's important to assess whether their participation aligns with shareholder interests. The legal framework ensures transparency and fairness in the process, but investors should still conduct their own due diligence to evaluate the offering's merits.

Charlotte, N.C., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. 

Akoustis expects to grant the underwriters a 30-day option to purchase additional shares of common stock sold in the offering solely to cover over-allotments.  The offering is subject to market and other conditions, and there can be no assurance as to whether or when such offering may be completed, or as to the actual size or terms of such offering. Certain of the Company’s directors, officers and other employees have indicated an intent to purchase shares of common stock in the offering.

Roth Capital Partners is acting as sole manager for the offering.

Akoustis intends to use the net proceeds from the proposed offering to fund operations and the growth of its business, including for capital expenditures, working capital, research and development, the commercialization of its technology, potential strategic transactions and for other general corporate purposes. 

A shelf registration statement relating to the shares of common stock to be issued in the proposed offering was previously filed with the Securities and Exchange Commission (the “SEC”) and is currently effective.  A preliminary prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC.  The shares of common stock may be offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement.  Copies of the preliminary prospectus supplement and the accompanying prospectus relating to the securities being offered may be obtained, when available, from Roth Capital Partners, LLC, 888 San Clemente, Suite 400, Newport Beach, CA 92660, by telephone at (800) 678-9147 or by email at rothecm@roth.com.  Electronic copies of the preliminary prospectus supplement and accompanying prospectus will also be available on the SEC’s website at http://www.sec.gov.

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, the shares of common stock, nor will there be any sale of the shares of common stock in any state or other jurisdiction in which such offer, solicitation or sale is not permitted.

About Akoustis Technologies, Inc.

Akoustis® (http://www.akoustis.com/) is a high-tech BAW RF filter solutions company that is pioneering next-generation materials science and MEMS wafer manufacturing to address the market requirements for improved RF filters — targeting higher bandwidth, higher operating frequencies and higher output power compared to legacy polycrystalline BAW technology. The Company utilizes its proprietary and patented XBAW® manufacturing process to produce bulk acoustic wave RF filters for mobile and other wireless markets, which facilitate signal acquisition and accelerate band performance between the antenna and digital back end. Superior performance is driven by the significant advances of poly-crystal, single-crystal, and other high purity piezoelectric materials and the resonator-filter process technology which enables optimal trade-offs between critical power, frequency and bandwidth performance specifications.

Akoustis plans to service the fast growing multi-billion-dollar RF filter market using its integrated device manufacturer (IDM) business model. The Company owns and operates a 125,000 sq. ft. ISO-9001:2015 registered commercial wafer-manufacturing facility located in Canandaigua, NY, which includes a class 100 / class 1000 cleanroom facility — tooled for 150-mm diameter wafers — for the design, development, fabrication and packaging of RF filters, MEMS and other semiconductor devices. Akoustis Technologies, Inc. is headquartered in the Piedmont technology corridor near Charlotte, North Carolina.

Forward-Looking Statements

This document includes “forward-looking statements” within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, each as amended, that are intended to be covered by the “safe harbor” created by those sections. These forward-looking statements include, but are not limited to, statements regarding the proposed public offering of common stock and the intended use of the net proceeds of such public offering. Forward-looking statements include all statements that are not historical facts and typically are identified by use of terms such as “may,” “might,” “would,” “will,” “should,” “could,” “project,” “expect,” “plan,” “strategy,” “anticipate,” “attempt,” “develop,” “help,” “believe,” “think,” “estimate,” “predict,” “intend,” “forecast,” “seek,” “potential,” “possible,” “continue,” “future,” and similar words (including the negative of any of the foregoing), although some forward-looking statements are expressed differently. Forward-looking statements are neither historical facts nor assurances of future results, performance, events or circumstances. Instead, these forward-looking statements are based on management’s current beliefs, expectations and assumptions, and are subject to risks and uncertainties. Factors that could cause actual results to differ materially from those currently anticipated include, without limitation, risks relating to our inability to obtain adequate financing and sustain our status as a going concern; our limited operating history; our inability to generate revenues or achieve profitability; the results of our research and development activities; our inability to achieve acceptance of our products in the market; the failure of our common stock to meet the minimum requirements for continued listing on the Nasdaq Capital Market; the possibility that the anticipated benefits from business acquisitions will not be realized in full or at all or may take longer to realize than expected; the possibility that costs or difficulties related to the integration of acquired businesses’ operations will be greater than expected and the possibility of disruptions to our business during integration efforts and strain on management time and resources; the impact of a pandemic or epidemic or a natural disaster, including the COVID-19 pandemic, the Russian-Ukrainian and Middle East conflicts and other sources of volatility on our operations, financial condition and the worldwide economy, including its impact on our ability to access the capital markets; increases in prices for raw materials, labor, and fuel caused by rising inflation; general economic conditions, including upturns and downturns in the industry; shortages in supplies needed to manufacture our products, or needed by our customers to manufacture devices incorporating our products; our limited number of patents; failure to obtain, maintain, and enforce our intellectual property rights; claims of infringement, misappropriation or misuse of third party intellectual property, including the lawsuit filed by Qorvo, Inc. in October 2021, that, regardless of merit, has resulted in significant expense; our inability to attract and retain qualified personnel; our reliance on third parties to complete certain processes in connection with the manufacture of our products; product quality and defects; existing or increased competition; our ability to successfully manufacture, market and sell products based on our technologies; our ability to meet the required specifications of customers and achieve qualification of our products for commercial manufacturing in a timely manner; our inability to successfully scale our New York wafer fabrication facility and related operations while maintaining quality control and assurance and avoiding delays in output; the rate and degree of market acceptance of any of our products; our ability to achieve design wins from current and future customers; contracting with customers and other parties with greater bargaining power and agreeing to terms and conditions that may adversely affect our business; risks related to doing business in foreign countries, including China; any security breaches, cyber-attacks or other disruptions compromising our proprietary information and exposing us to liability; our failure to innovate or adapt to new or emerging technologies, including in relation to our competitors; our failure to comply with regulatory requirements; results of any arbitration or litigation that may arise; stock volatility and illiquidity; dilution caused by any future issuance of common stock or securities that are convertible into or exercisable for common stock; our failure to implement our business plans or strategies; and our ability to maintain effective internal control over financial reporting. These and other risks and uncertainties are described in more detail in the Risk Factors and Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of the Company’s most recent Annual Report on Form 10-K and in subsequently filed Quarterly Reports on Form 10-Q. Considering these risks, uncertainties and assumptions, the forward-looking statements regarding future events and circumstances discussed in this document may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements included in this document speak only as of the date hereof and, except as required by law, we undertake no obligation to update publicly or privately any forward-looking statements, whether written or oral, for any reason after the date of this document to conform these statements to new information, actual results or to changes in our expectations.


FAQ

What is Akoustis Technologies, Inc. planning to do?

Akoustis Technologies, Inc. plans to offer and sell shares of its common stock in an underwritten public offering.

What will the underwriters be granted?

The underwriters will be granted a 30-day option to purchase additional shares of common stock sold in the offering solely to cover over-allotments.

What is the intended use of the net proceeds from the proposed offering?

The net proceeds from the proposed offering will be used for operations, capital expenditures, working capital, research and development, the commercialization of its technology, potential strategic transactions, and for other general corporate purposes.

Who is acting as the sole manager for the offering?

Roth Capital Partners is acting as the sole manager for the offering.

Where can copies of the preliminary prospectus supplement and accompanying prospectus be obtained?

Copies of the preliminary prospectus supplement and the accompanying prospectus relating to the securities being offered may be obtained from Roth Capital Partners, LLC, by telephone at (800) 678-9147 or by email at rothecm@roth.com.

AKOUSTIS TECHNOLOGIES, INC.

NASDAQ:AKTS

AKTS Rankings

AKTS Latest News

AKTS Stock Data

5.75M
149.46M
3.32%
14.03%
3.45%
Communication Equipment
Telephone & Telegraph Apparatus
Link
United States of America
HUNTERSVILLE